Published price vs quote-only
Shed vs Wellmedr: Which One Publishes Its Price? (2026)
Shed quotes after intake vs Wellmedr $89/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 9.4 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Comparing Shed with Wellmedr means comparing two business models more than two medications. The molecules overlap; the terms do not.
A discount off an undisclosed number is not a price. Shed quotes after intake, while Wellmedr states Semaglutide from $89/mo on the 1-year plan on the way in — which makes one of these two comparable in advance and the other not.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Wellmedr — Semaglutide from $89/mo on the 1-year plan. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Least friction to get going
- Wellmedr — Same-day review, then free overnight shipping.
- Longest public track record
- Shed — 8,500 patient reviews against 4,925.
Shed vs Wellmedr: the specification
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| Shed | Wellmedr | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | Semaglutide from $89/mo on the 1-year plan |
| Rate after promotions | not published before intake | $89/mo |
| Pricing structure | Quoted only after intake | Price locked for the life of the plan |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide |
| Price transparency | Quote only, after intake | Partly published |
| How fast you start | 2-minute approval assessment | Same-day review |
| Membership fee | Not stated | Not stated |
| State coverage | Not published | Not published |
| Support model | Coaching built into the plan | No coaching program stated |
| Patient reviews | 8,500 | 4,925 |
| eRxDoctor score | 9.9/10 | 9.4/10 |
What Shed and Wellmedr actually cost over a year
A first-month price is a customer-acquisition number. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Shed | Wellmedr | |
|---|---|---|
| First month | Not published | $89 |
| Months 2 onward | Not published | $89/mo |
| 6-month total | Not computable | $534 |
| 12-month total | Not computable | $1,068 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
What you know before you hand over a medical history
Wellmedr states its terms upfront: Semaglutide from $89/mo on the 1-year plan, price locked for the life of the plan. You can decide whether it fits your budget without giving anyone a medical history.
Shed runs the other way around — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
If you do go through Shed's intake, ask for the month-two price in writing before you pay for month one. That single question resolves most of the disclosure gap.
Shed: what you are buying
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month.
The process is 2-minute approval assessment, then home delivery after clinician review. On money, expect quoted only after intake — quote only, after intake.
Support: continuous coaching built into every treatment plan. The medications on offer are name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- 10% off your first month for new patients
- Fast 2-minute approval assessment
- Continuous coaching is integrated into treatment, not just a prescription
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
Shed cons
- Name-brand options carry significantly higher costs than compounded alternatives
- Standard pricing is not published, you receive a personalized quote after intake
- Coaching-bundled model can cost more than bare-prescription platforms
Set beside Wellmedr, the thing to weigh: you cannot know what you will pay until you have finished the intake.
Inside the Wellmedr program
The pitch is locked-in pricing with no dose-based increases at one of the lowest published rates. GLP-1 Plans Starting at Just $89/Month
You start with same-day review; medication arrives via free overnight shipping. The price behaves as price locked for the life of the plan.
Same-day clinician review. The formulary covers compounded semaglutide.
Wellmedr pros
- Lifetime locked-in pricing
- No dose-based price increases
Wellmedr cons
Against Shed specifically, the trade you are making: the $89 rate is tied to a one-year commitment and the platform publishes little else.
Shed or Wellmedr: matching the program to the patient
Choose Shed if:
- delivery works the way you want it to: home delivery after clinician review
- you want to start on their timeline: 2-minute approval assessment
- the level of clinical contact suits you: continuous coaching built into every treatment plan
- the feature you would actually use: one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
Choose Wellmedr if:
- what it leads on is worth paying for in your case: locked-in pricing with no dose-based increases at one of the lowest published rates
- you want the price you sign up at to survive titration
- you want to start on their timeline: same-day review
- the level of clinical contact suits you: same-day clinician review
The trade-offs, stated plainly
On price. Only Wellmedr publishes a rate you can plan against (Semaglutide from $89/mo on the 1-year plan). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On medication. Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1; Wellmedr covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. The support models differ — continuous coaching built into every treatment plan against same-day clinician review — and that difference is felt in week two, not week one.
The medication, not the platform
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
Shed vs Wellmedr: common questions
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to Wellmedr, which publishes Semaglutide from $89/mo on the 1-year plan upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which is cheaper to start, Shed or Wellmedr?
Only Wellmedr publishes a first-month figure (Semaglutide from $89/mo on the 1-year plan). The other quotes after intake, so a starting-cost comparison is not available in advance.
How fast can I start with Shed compared with Wellmedr?
Shed advertises 2-minute approval assessment, with home delivery after clinician review. Wellmedr advertises same-day review, with free overnight shipping. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are Shed and Wellmedr legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Shed operates on quoted only after intake with pricing quote only, after intake, Wellmedr on price locked for the life of the plan, partly published. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Neither Shed nor Wellmedr penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; Wellmedr leads on locked-in pricing with no dose-based increases at one of the lowest published rates.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- Shed vs Elevate HealthPublished price vs quote-only
- Shed vs TMatesPublished price vs quote-only
- Wellmedr vs WellorithmPublished price vs quote-only
- Wellmedr vs EmbodyTirzepatide access
- JoinFridays vs WellorithmPublished price vs quote-only
- JoinFridays vs Start WillowPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or Wellmedr, and does not sell treatment. Read our ranking methodology.